Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7115627 Glycinamides as factor Xa inhibitors

Patent 7115627 was granted and assigned to Bristol-Myers Squibb on October, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11944631 Combination therapies
0
Edits on 29 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2024
Edits on 31 Aug, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 31 Aug, 2023
Edits made to:
Article (+192 characters)
Article

Patent abstract

The present application describes glycinamidic compounds and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.

Edits on 23 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07115627 Glycinamides as factor Xa inhibitors US Patent 7115627 Glycinamides as factor Xa inhibitors

Infobox
Patent Number
0711562700
Patent Number
711562700
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0711562700
Edits on 3 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
071156270
Date of Patent
October 3, 2006
0
Patent Application Number
103040700
Date Filed
November 25, 2002
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=071156270
Patent Primary Examiner
‌
Bruck Kifle
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
071156270
Date of Patent
October 3, 2006
0
Patent Application Number
103040700
Date Filed
November 25, 2002
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=071156270
Patent Primary Examiner
‌
Bruck Kifle
0
Edits on 7 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 7 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07115627
Edits on 17 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 17 Nov, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07115627 Glycinamides as factor Xa inhibitors

Infobox
Is a
Patent
Patent
Current assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07115627
Date of patent
October 3, 2006
Patent application number
10304070
Date Filed
November 25, 2002
Patent primary examiner
‌
Bruck Kifle

Find more entities like US Patent 7115627 Glycinamides as factor Xa inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo